Clinical trial
SGLT2i Use in France Based on SNDS Data Claim
NCT05882071 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SGLT2i Use in France Based on SNDS Data Claim
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 15, 2023
- Completion date
- November 30, 2026
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.